Persistence and clinical significance of hepatitis G virus infections in injecting drug users

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 586-592

  Thomas, David L ^a   Nakatsuji, Yoshiyuki ^a   Shih, James W ^a   Alter, Harvey J ^a   Nelson, Kenrad E ^a   Astemborski, Jacquie A ^a   Lyles, Cynthia M ^a   Vlahov, David ^a  

^a 1147 Ross Research Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; DRUG ABUSE; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS G VIRUS; HEPATITIS VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; VIRUS REPLICATION;

EID: 0030840838     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514078     Document Type: Article

References (26)

1. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
3. Chemello L, Cavalletto D, Pontisso P, et al. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology 1993; 17:179-82.
4. Marcellin P, Martinot-Peignoux M, Gabriel F, et al. Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. J Hepatol 1993;19:167-70.
5. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995;15:110-20.
6. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995;1: 564-9.
7. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
8. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-5.
9. Alter MJ, Gallagher M, Morris T, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741-6.
10. Alter HJ, Nakatsuji Y, Melpolder JC, et al. The incidence and disease implications of transfusion associated hepatitis G virus infection. N Engl J Med 1997;336:747-54.
11. Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schlüter W. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174:1320-3.
12. Berg T, Naumann U, Fukumoto T, et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996;62:711-4.
13. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
14. Heringlake S, Osterkamp S, Trautwein C, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996;348: 1626-9.
15. Donahue JG, Nelson KE, Munoz A, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991;134:1206-11.
16. Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immuno-deficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990;132:847-56.
17. Anthony JC, Vlahov D, Celentano DD, et al. Self-report interview data for a study of HIV-1 infection among intravenous drug users: description of methods and preliminary evidence on validity. J Drug Issues 1991;21:739-57.
18. Thomas DL, Vlahov D, Solomon L, et al. Correlates of Hepatitis C Virus infections among injection drug users in Baltimore. Medicine 1995;74: 212-20.
19. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol 1995; 142:331-41.
20. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996;174:690-5.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay, and nested polymerase chain reaction analysis. Hepatology 1992; 16:300-5.
23. Norman JE, Beebe GW, Hoofnagle JH, Seeff LB. Mortality follow-up of the 1942 epidemic of hepatitis B in the US Army. Hepatology 1993; 18:790-7.
24. Seeff LB, Beebe GW, Hoofnagle JH, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987;316:965-70.
25. Dille BJ, Surowy TK, Gutierrez RA, et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997;175: 458-61.
26. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997;349:318-20.